NEW MJ NEWS

AbbVie to Host Second-Quarter 2021 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its second-quarter 2021 financial results on Friday, July 30, 2021, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-second-quarter-2021-earnings-conference-call-301326236.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The Alkaline Water Company Inc. (WTER) President & CEO Discusses Company’s Double-Digit 2020 Growth Despite COVID-19 Challenges

The Alkaline Water Company President & CEO Discusses Company’s Double-Digit 2020 Growth…

PotNetwork Holding, Inc. (POTN) Solidified with Appointment of Distinguished South Florida Cardiovascular Specialist

Advisory Board Solidified with PotNetwork Holding, Inc.’s Appointment of Distinguished South Florida…

Jushi Holdings Inc. (JUSHF) to Host Fourth Quarter and Full Year 2020 and First Quarter 2021 Financial Results Conference Call

Jushi Holdings Inc. to Host Fourth Quarter and Full Year 2020 and…

$PMCB Drug Delivery Platform Limited only by Imagination

Small Cap IR Initiates Analyst Coverage – PharmaCyte Biotech Drug Delivery Platform…